Skip to main content
OpenTrials
Completed

NCT Number: NCT03636633

The Effect of Inspiratory Muscle Training and Respiratory Physiotherapy on Pulmonary Functions, Respiratory Muscle Strength and Functional Capacity in Patients With Robotic Heart Surgery

During the past decade, especially with the advancement of technology, major innovations and developments have been observed in the field of surgery. Cardiac surgery is one of the important area of the surgery who renews itself day by day and adds innovations to the nature in terms of patients' comfort. One of the greatest developments in cardiac surgery in this sense is the tendency to reduce the size of the incisions with less interventional procedures. Robotic surgery is getting more and more meaningful in this area. Despite the downsizing of the surgical incisions, postoperative pulmonary complications have not completely disappeared in the robotic cardiac surgery. Major respiratory problems following traditional cardiac surgery are gas exchange problems, atelectasis, decreased coughing force and sputum retention. The effectiveness of respiratory physiotherapy applied after traditional cardiac surgery for the resolution of these complications has been proved by various investigations. Inspiratory muscle training (IMT) has been found to improve autonomic modulation in heart failure patients as well as to increase inspiratory muscle strength in applied patient populations, reduce blood pressure in hypertensive patients, and increase functional capacity in elderly individuals. Considering these benefits, when inspiratory muscle training is given to people with traditional cardiac surgery, respiratory muscle strengths, respiratory functions and functional capacities are increased compared to those not given to these patients. However, although there are complications after robotic cardiac surgery, there are no studies in the literature about respiratory physiotherapy or inspiratory muscle training. Thus, the subject of this study is the comparison of the effects of standard respiratory physiotherapy and standard respiratory physiotherapy plus inspiratory muscle training on the respiratory functions, respiratory muscle strength and functional capacity of the patients with the robotic heart surgery.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Acıbadem MAA University Maslak Hospital

Istanbul, 34457, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Being suitable for robotic cardiac surgery,
  • Being hospitalized to have a robotic heart surgery,
  • No complications during surgery,
  • To be extubated in intensive care unite after surgery ,
  • Stable clinical condition,
  • To be transferred from ICU to the hospital room on the first day after surgery.

Exclusion criteria

  • Chronic obstructive pulmonary disease,
  • Unstable angina,
  • Acute decompensated heart failure,
  • Acute pericarditis and myocarditis,
  • Complex arrhythmia,
  • Uncontrolled hypertension,
  • Serious orthopedic and neurological impairment,
  • Uncontrolled diabetes,
  • Body Mass Index > 30.

Treatment and study plan

Standard respiratory physiotherapy

Other

Standard respiratory physiotherapy content; diaphragmatic breathing, pursed lip breathing, segmental breathing, incentive spirometer exercises (Triflo) and coughing techniques.

Standard respiratory physiotherapy and inspiratory muscle training

Other

Standard respiratory physiotherapy content; diaphragmatic breathing, pursed lip breathing, segmental breathing, incentive spirometer exercises (Triflo) and coughing techniques. Addition to that, threshold IMT device will be used for the training. Training intensity will set at 40% of the maximum inspiratory pressure.

Primary outcomes

  1. Change from baseline Forced Vital Capacity (FVC) at 4 weeks

    Time frame: Four weeks

  2. Change from baseline Forced Expiratory Volume in 1 second (FEV1) at 4 weeks

    Time frame: Four weeks

  3. Change from baseline Peak Expiratory Flow (PEF) at 4 weeks

    Time frame: Four weeks

  4. Change from baseline maximum inspiratory pressure (MIP) at 4 weeks

    Time frame: Four weeks

  5. Change from baseline maximum expiratory pressure (MEP) at 4 weeks

    Time frame: Four weeks

  6. Change from baseline distance covered in six-minute walk test (6MWT) at 4 weeks

    Time frame: Four weeks

  7. Change from baseline carbon monoxide diffusion capacity of the lungs (DLCO) at 4 weeks

    Time frame: Four weeks

Secondary outcomes

  1. Fatigue Severity Scale

    Time frame: Four weeks

    The 9 item scale which measures the severity of fatigue and its effect on a person's activities and lifestyle in patients with a variety of disorders. Assessment type: Patient reported outcomes.The items are scored on a 7 point scale with 1 = strongly disagree and 7= strongly agree.The minimum score = 9 and maximum score possible = 63. Higher the score = greater fatigue severity.

  2. Fatigue Impact Scale

    Time frame: Four weeks

    The fatigue impact scale was developed to assess the symptom of fatigue as part of an underlying chronic disease or condition. Consisting of 40 items, the instrument evaluates the effect of fatigue on three domains of daily life: cognitive functioning, physical functioning, and psychosocial functioning. Respondents are asked to rate the extent to which fatigue has interfered with certain aspects of their day-to-day functioning using a scale that ranges from 0 ("no problem") to 4 ("extreme problem"). Scores are then tallied to produce an overall score with a potential maximum of 160. Subscale scores can also be calculated to give a more nuanced impression of fatigue.

Sponsors and collaborators

Lead sponsor

Acibadem University

Other

Registry information

Important dates

Study start
2018
Primary completion
2019
Study completion
2021
First posted
Aug 17, 2018
Registry last updated
Apr 29, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.